Results of Aethlon's Hemopurifier therapy on Ebola patient to be released

Aethlon Medical's Hemopurifier was used on an Ebola patient.
Aethlon Medical's Hemopurifier was used on an Ebola patient. | Aethlon Medical

Results from a new treatment that may help fight Ebola will be released Friday in Philadelphia.

Hemopurifier therapy from Aethlon Medical was given to a patient infected with the virus at Frankfurt University Hospital in Germnay. On Nov. 5, officials at the hospital said the patient was expected to make a full recovery after suffering from multiple organ failure.

The results of the treatment will be presented during the American Society of Nephrology (ASN) Annual Meeting by Dr. Helmut Geiger of Goethe University in Frankfurt. The patient infected with the virus was given the Hemopurifier therapy through special approval from the Federal Institute for Drugs and Medical Devices in Germany, Aethlon said.

The Hemopurifier is a “bio-filtration device” developed by Aethlon to strengthen immunosuppressive proteins, leading to the rapid elimination of viruses from the circulatory system. No antiviral therapy or vaccine has proven to be effective against Ebola, and more than 5,000 deaths have been atributed to the virus in the recent outbreak in Africa, the World Health Organization said.

Aethlon said the Hemopurifier has been successfully administered to about 100 individuals with HIV and Hepatitis C. The company said it is preparing to start clinical trials in the U.S. after securing approval from the U.S. Food and Drug Administration.